Osmolar-gap in the setting of metformin-associated lactic acidosis
<h3>Rationale</h3><p dir="ltr">Metformin-associated lactic acidosis (MALA) is a rare adverse effect that has significant morbidity and mortality. MALA is a high anion gap (AG), nonosmolar acidosis. Associated osmolar-gap (OG) is rarely reported, so finding an OG may make...
محفوظ في:
| المؤلف الرئيسي: | Mohamed Nabil Elshafei (9960500) (author) |
|---|---|
| مؤلفون آخرون: | Mohammed Alamin (20375244) (author), Mouhand F.H. Mohamed (16932579) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The impact of metformin therapy for gestational diabetes on fetal growth in women with risk factors for fetal growth restriction- a registry-based study from Qatar
حسب: Komal Rafique (17075074)
منشور في: (2023) -
Impact of metformin treatment on cobalamin status in persons with type 2 diabetes
حسب: Sundus Fituri (17945294)
منشور في: (2023) -
Metformin: Is it a drug for all reasons and diseases?
حسب: Chris R. Triggle (4278688)
منشور في: (2022) -
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
حسب: Samson Samuel (6828956)
منشور في: (2019) -
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
حسب: Kheraldine, Hadeel
منشور في: (2025)